Sign up for the Today newsletter
Get everything you need to know to start your day, delivered right to your inbox every morning.
UMass Chan Medical School rescinds dozens of offers amid funding uncertainty
The impacted students were offered priority consideration for the next admission cycle without the need to submit another application.
The University of Massachusetts Chan Medical School rescinded several dozen offers from prospective graduate students at its Morningside Graduate School of Biomedical Sciences, citing federal funding uncertainties.
In a statement, the school informed applicants who received “provisional offers of acceptance” for PhD programs in biomedical sciences that their acceptances were revoked.
“With uncertainties related to the funding of biomedical research in this country, this difficult decision was made to ensure that our current students’ progress is not disrupted by the funding cuts and that we avoid matriculating students who may not have robust opportunities for dissertation research,” UMass Chan said in the statement.
Advertisement:
The impacted prospective students were offered priority consideration for the next admission cycle without the need to submit another application, according to the statement.
College Uncertainty:
Current PhD students and the applicants to UMass Chan’s other graduate schools — the T.H. Chan School of Medicine and the Tan Chingfen Graduate School of Nursing — are not impacted by the move, according to the statement.
UMass Chan said in the statement that it is “not alone in making such a decision.” The Harvard Graduate School of Arts and Sciences will reject all waitlisted applications. University of Pennsylvania directed department chairs to majorly reduce its admission rates in their graduate programs, possibly rescinding some offered acceptances. University of California San Diego cautioned accepted graduate students that funding will not be guaranteed.
Advertisement:
UMass Chan, like several other major institutions, also announced an immediate hiring freeze this week.
The Trump administration’s decision to significantly reduce grants from the National Institute of Health could have far-reaching effects on not only medical research in premium universities but also on hospitals conducting clinical research on diseases.
To comment, please create a screen name in your profile
To comment, please verify your email address
Conversation
This discussion has ended. Please join elsewhere on Boston.com